Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PMS2 C-terminal like (PMS2CL, also called PMS2P13 and related names) is a pseudogene similar in sequence to the mismatch repair gene PMS2. PMS2CL does not produce a functional protein. Pseudogenes like PMS2CL can complicate genetic analysis of PMS2 due to high sequence similarity, which may cause artifacts in genetic testing. The functional PMS2 gene encodes a DNA repair enzyme essential in correcting replication errors, and mutations in PMS2 can cause Lynch syndrome, a hereditary cancer predisposition. However, PMS2CL itself does not play a functional role in DNA mismatch repair or in disease pathogenesis. The PMS2 gene is an active component of DNA mismatch repair, crucial for genomic stability. However, PMS2CL (and similar pseudogenes on chromosome 7) lack coding potential, serving as nonfunctional DNA elements. Their main biological relevance is the potential to confound genetic diagnostics due to sequence homology with PMS2. No drugs, biomarkers, or therapeutic roles are associated with PMS2CL.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PMS2 C-terminal like pseudogene (PMS2CL).